Synjardy 12.5Mg/850Mg 60Tab

Synjardy is a medication belonging to the class of antidiabetic drugs, containing two active substances: Empagliflozin and Linagliptin. This medication is used to manage blood sugar levels in patients with type 2 diabetes. It works by lowering blood glucose levels through increased insulin secretion and reduced glucose production in the liver. This product was developed by Boehringer Ingelheim and is subject to regulatory approvals from the Saudi Food and Drug Authority.

Generic Name

Empagliflozin and Linagliptin

Product Type and Composition

Tablets, 12.5Mg/850Mg, pack containing 60 tablets

Indications

• Treatment of type 2 diabetes as part of a diet and exercise program.
• May be used with other antidiabetic medications if needed.

Possible Side Effects

• Abdominal pain.
• Nausea.
• Diarrhea.
• Skin reactions.
• Contact a healthcare provider if severe side effects occur.

How to Use

Take one tablet daily with or without food, as directed by your doctor. Do not exceed the recommended dose.

Drug Interactions

• Avoid using with other medications containing DPP-4 inhibitors.
• Other diabetes medications may affect the effectiveness of Synjardy.
• Consult your doctor before taking any new medications.
• Avoid alcohol during treatment.

Warnings for Pregnancy and Breastfeeding

It is advised to consult a doctor before using this product during pregnancy or breastfeeding.

Warnings and Precautions

• Do not use if there is a history of allergy to any of its components.
• Caution in patients with kidney problems.
• Regular monitoring of blood sugar levels is required.

Storage Instructions

• Store at room temperature (15-25°C) in a dry place.
• Protect from light and moisture.
• Keep in the original packaging until use.
• Keep out of reach of children.